If middle-class Americans lose their jobs to AI, that could mean fewer cash sales of weight-loss drugs like Zepbound..
Share this article
Corporate
Score 65
Bearish
Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales
Mar 17, 2026 18:28 UTC
LLY, ZEPB, XLV
Medium term
Related Articles
Score 45
Rising Oil Prices and Meatpacking Strike Pose Indirect Threat to Olive Garden Sales
Mar 17, 19:54
Score 65
Bearish
Orlando Bravo says some software names hit by AI deserve a valuation cut
Mar 17, 19:36
Score 85
Bullish
AI Drone Software Stock Jumps 700% in Best IPO Since Newsmax
Mar 17, 19:20
Score 75
Bullish
This biotech is working on a GLP-1 pill that could be better than the Wegovy version
Mar 17, 19:20
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.